Serums 8.1.2
Update on NAFLD genetics: from new variants to the clinic
One study has also identified the liver, skeletal muscle and adipose tissue as additional GLP-1 targets (39), further highlighting its diverse and significant biological functions
Time to clinical benefit of dapagliflozin in patients with heart failure with mildly reduced or preserved ejection fraction: a prespecified secondary analysis of the DELIVER randomized clinical trial
effects on liver steatosis, hepatocyte ballooning, inflammation, fibrosis (F1-F3), cirrhosis (F4), treatment duration, and safety (treatment-emergent adverse events)
People who have sensitive skin, an active infection, or are pregnant should talk to one of our specialists to make sure they can get the treatment